Cogent Biosciences (COGT) earnings, Oct 28, 2026: EPS −9%, stock −0.8%
In brief
Cogent Biosciences reported on Oct 28, 2026. Earnings per share changed −9% year over year, 15.5% below the estimate; revenue 0%. The stock opened with a +2.0% gap and closed the day −0.8% (Oct 29, 2026). The stock is now 27.6% below its 52-week high, +115.0% over 12 months. Next report: Mar 16, 2027.
EPS vs estimate−15.5%
EPS, YoY−9%
Revenue, YoY0%
Gap · day+2.0% · −0.8%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 5, 2026 | +0.5% | +0.7% |
| Jun 30, 2026 | −0.3% | −0.6% |
| Jul 28, 2026 | +0.2% | +0.6% |
| Oct 28, 2026 | +2.0% | −0.8% |
Next-quarter estimates, ratings and the COGT chart are in the terminal.
Open the terminalFAQ
When is Cogent Biosciences's next earnings report?
Mar 16, 2027. The date comes from daily data and is corrected if the company moves it.
How did Cogent Biosciences stock react to the report?
Opening gap +2.0%, day's result −0.8%.
Did Cogent Biosciences's earnings grow?
Earnings per share fell 9% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.